+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
Asthma - Pipeline Insight, 2024 - Product Thumbnail Image

Asthma - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Acute Respiratory Distress Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Respiratory Distress Syndrome - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Nasal Polyposis - Pipeline Insight, 2024 - Product Thumbnail Image

Nasal Polyposis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 220 Pages
  • Global
From
Cystic Fibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Pertussis - Pipeline Insight, 2024 - Product Thumbnail Image

Pertussis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 70 Pages
  • Global
From
Asthma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Asthma - Epidemiology Forecast - 2034

  • Report
  • April 2024
  • 152 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034

  • Report
  • April 2024
  • 75 Pages
  • Global
From
Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024 - Product Thumbnail Image

Ventilator Associated Pneumonia (VAP) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Lung Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Lung Injury - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more